Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Accumulated Expenses: 2020-2025

Historic Accumulated Expenses for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $48.1 million.

  • Maravai Lifesciences Holdings' Accumulated Expenses rose 23.75% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.1 million, marking a year-over-year increase of 23.75%. This contributed to the annual value of $39.6 million for FY2024, which is 34.30% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Accumulated Expenses of $48.1 million as of Q3 2025, which was down 4.12% from $50.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Accumulated Expenses registered a high of $70.1 million during Q1 2023, and its lowest value of $24.8 million during Q2 2021.
  • For the 3-year period, Maravai Lifesciences Holdings' Accumulated Expenses averaged around $48.6 million, with its median value being $48.1 million (2025).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Accumulated Expenses skyrocketed by 116.18% in 2023 and then plummeted by 49.47% in 2024.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Accumulated Expenses stood at $34.6 million in 2021, then spiked by 54.37% to $53.4 million in 2022, then increased by 12.86% to $60.2 million in 2023, then slumped by 34.30% to $39.6 million in 2024, then rose by 23.75% to $48.1 million in 2025.
  • Its last three reported values are $48.1 million in Q3 2025, $50.2 million for Q2 2025, and $44.6 million during Q1 2025.